Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

184.49 USD +1.88 (+1.03%)
Official Closing Price Updated: 7:50 PM EDT, Apr 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
Contrary to the strength in the broader market, biotech stocks ended the week ending April 9 lower. The weakness partly reflected a ... 
Tags Biotech BPMC EARS
From Benzinga
Which Stock Is Likely to Be the Biggest Winner: Lilly, Vir, or GlaxoSmithKline?
One of the three clearly has the most upside potential. 
Tags GSK VIR Market News
From Motley Fool
The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags IBB VCEL LHDX
From Benzinga
Provention Bio Stock Craters After FDA Flags Deficiencies In PK Profiles From Teplizumab Trials For Diabetes
Provention Bio Inc(NASDAQ:PRVB)revealed it had received a notificationon April 2 from the FDA stating that ... 
Tags Diabetes General LLY
From Benzinga
Global COVID-19 cases top 133 million as Brazil and India become flashpoints
The number of global confirmed cases of the coronavirus-borne illness COVID-19 climbed above 133 million on Thursday and the death toll edged closer to 3 million, as India and Brazil became flashpoints... 
Tags AZN BNTX PFE
From MarketWatch
The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BLPH FIXX NBSE
From Benzinga
Eli Lilly-Incyte's Baricitinib Study In Hospitalized COVID-19 Patients Fails To Meet Main Goal
Eli Lilly And Co(NYSE:LLY) andIncyte Corporation(NASDAQ:INCY)have reported ... 
Tags Biotech Covid/19 Briefs
From Benzinga
Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients
- Randomized, double-blind, placebo-controlled study of 1,525 patients did not meet statistical significance on primary endpoint (progression to non-invasive ventilation or invasive mechanical... 
From PR Newswire
The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags PRAH PAVM GRCL
From Benzinga
Lilly and Incyte communicate review extension of supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis
Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application... 
From PR Newswire
Lilly Confirms Date and Conference Call for First-Quarter 2021 Financial Results Announcement
Eli Lilly and Company (NYSE: LLY) will announce its first-quarter 2021 financial results on Tuesday, April 27, 2021. Lilly will also conduct a conference call on that day with the investment community... 
From PR Newswire
Is Silicon Valley Replacing Big Pharma In Neuroscience?
The following article is sponsored by Mind Cure. The information contained in this article in no way represents investment advice or ... 
Tags CMPS General LLY
From Benzinga
Noteworthy ETF Outflows: XLV, ABT, MDT, LLY
Symbols mentioned in this story: XLV, ABT, MDT, LLY Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Better Buy for 2021: Pfizer or Gilead?
In a post-pandemic world, one company has the lower valuation and higher dividend yield to be a success. 
Tags IHE LLY JNJ
From Motley Fool
The Week Ahead In Biotech: Regeneron, Supernus FDA Decisions, Cancer Conference Presentations In The Spotlight
Biotech stocks ended the holiday-shortened week ended April 1 in the green, catalyzed by the broader market rebound and a slew of ... 
Tags ALPN GLYC MTEM
From Benzinga
Fortress Biotech's Partner Firm Expands Footprint In Dermatology With Qbrexza Acquisition
Fortress Biotech Inc's(NASDAQ:FBIO) partner companyJourney Medical Corporationhasagreed to ... 
Tags News Health Care Benzinga
From Benzinga
Lilly to Host Sustainability Webcast to Provide Overview of Environmental, Social and Governance (ESG) Efforts
Eli Lilly and Company (NYSE: LLY) will host a webcast for the investment community, media and the general public on May 4, 2021 to provide an overview of the company's strong commitment to... 
From PR Newswire
Survey reveals healthcare professionals believe greater collaboration is needed to improve patient outcomes in diabetes care
- More than 80 percent of HCPs wish they had the time to more closely track patients who are seeing multiple providers 
From PR Newswire
Could Pfizer's and Lilly's Long-Awaited Osteoarthritis Drug Flop?
It looks like an uphill battle for tanezumab. 
Tags PFE Market News LLY
From Motley Fool
The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ORPH GWPH DARE
From Benzinga
Why Humanigen Stock Is Skyrocketing Today
The company's investigational coronavirus treatment could hit the market soon. 
Tags Market News LLY GILD
From Motley Fool
Eli Lilly-Vir Bamlanivimab-VIR-7831 Combo Reduces Viral Load By 70% In Low-Risk COVID-19 Patients
Eli Lilly And Co(NYSE:LLY),Vir Biotechnology Inc(NASDAQ:VIR), andGlaxoSmithKline ... 
Tags General LLY Benzinga
From Benzinga
Lilly, Vir Biotechnology and GSK Announce Positive Topline Data from the Phase 2 BLAZE-4 Trial Evaluating Bamlanivimab with VIR-7831 in Low-Risk Adults with COVID-19
– In combination, the two monoclonal antibodies demonstrated a 70% relative reduction in persistently high viral load at day 7 compared to placebo – 
From GlobeNewswire News Releases
Lilly, Vir Biotechnology and GSK Announce Positive Topline Data from the Phase 2 BLAZE-4 Trial Evaluating Bamlanivimab with VIR-7831 in Low-Risk Adults with COVID-19
- In combination, the two monoclonal antibodies demonstrated a 70% relative reduction in persistently high viral load at day 7 compared to placebo - 
From PR Newswire
This Stalwart's Growth Story Isn't Over Yet
It's a big-name pharma with a storied history, but Eli Lilly still has plenty of room left to run. 
Tags JNJ ABBV LLY
From Motley Fool
2 Surefire Stocks to Buy for a Biden Bull Market
These two healthcare stocks could be big winners in a post-pandemic economy. 
Tags SNY BIIB Market News
From Motley Fool
NetworkNewsAudio – 180 Life Sciences Corp. (NASDAQ: ATNF) Developing Groundbreaking Anti-Inflammatory Therapeutics
From InvestorBrandNetwork
Looking Into Eli Lilly's Return On Capital Employed
Looking at Q4, Eli Lilly (NYSE:LLY) earned $1.99 billion, a 55.84% increase from the preceding quarter. Eli Lilly ... 
Tags Markets BZI/ROCE Market News
From Benzinga
A Peek Into The Markets: US Stock Futures Gain Ahead Of Economic Reports
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones added around 200 200 points in the ... 
Tags Global Benzinga AMT
From Benzinga
5 Stocks To Watch For March 26, 2021
Some of the stocks that may grab investor focus today are: Progress Software Corp (NASDAQ: PRGS) reported better-than-expected ... 
Tags Earnings LLY Trading Ideas
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.